​

TG Therapeutics Ownership | Who Owns TG Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

TG Therapeutics Ownership Summary

TG Therapeutics is owned by 77.80% institutional investors, 7.47% insiders, and 14.73% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 15.27% of TGTX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.24% of its assets in TG Therapeutics shares.

TGTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTG Therapeutics77.80%7.47%14.73%
SectorHealthcare Stocks 244.37%12.11%-156.48%
IndustryBiotech Stocks 379.01%11.75%-290.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de22.05M15.27%$1.21B
Vanguard group15.84M10.89%$472.22M
Blackrock11.39M7.79%$202.60M
State street7.79M5.39%$427.79M
Vanguard capital management6.15M4.26%$337.85M
Geode capital management3.64M2.52%$200.14M
D. e. shaw3.40M2.35%$186.84M
Soleus capital management2.93M2.03%$160.86M
Price t rowe associates inc /md/2.77M1.92%$152.06M
Clearbridge investments2.65M1.83%$145.60M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
M28 capital management lp88.35K10.29%$4.85M
Act capital management251.03K9.01%$13.79M
Exome asset management164.91K5.59%$9.06M
Soleus capital management2.93M5.54%$160.86M
Ghost tree capital500.00K2.79%$8.89M
Opaleye management535.00K2.66%$29.39M
Knott david m jr66.84K1.94%$3.67M
Penn capital management company536.07K1.87%$29.51M
Pandora wealth78.10K1.41%$2.33M
Quantum private wealth86.01K1.21%$4.73M

Top Buyers

HolderShares% AssetsChange
D. e. shaw3.40M0.09%2.81M
Price t rowe associates inc /md/2.77M0.02%2.13M
Sixth street partners management company1.31M0.01%1.31M
Two sigma investments, lp2.47M0.10%926.66K
Barclays957.85K0.01%841.19K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---1.73M
Citadel advisors537.17K0.00%-1.39M
Soleus capital management2.93M5.54%-1.10M
Vestal point capital, lp---1.05M
State street7.79M0.01%-863.29K

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company1.31M0.01%1.31M$72.14M
Norges bank401.50K0.00%401.50K$12.09M
Weiss asset management lp375.08K0.22%375.08K$20.61M
Frontier capital management368.81K0.19%368.81K$20.26M
Arete wealth advisors214.46K0.39%214.46K$11.78M

Sold Out

HolderChange
Hfm investment advisors-1.00
Global financial private client-2.00
Annis gardner whiting capital advisors-3.00
Mendota financial group-4.00
Financial gravity asset management-5.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202645818.96%112,378,3396.64%771.46%25422.12%12419.23%
Mar 31, 2026190-48.37%32,544,367-68.44%220.45%93-51.05%50-54.55%
Dec 31, 2025250-32.98%81,888,299-17.29%561.24%124-19.48%74-43.94%
Sep 30, 2025238-35.68%62,326,392-35.80%420.97%92-50.27%94-7.84%
Jun 30, 2025376-4.08%101,484,9743.38%691.54%187-6.50%105-10.26%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF8.03M5.24%-2.49K
Vanguard MStar Total Stk Mkt Idx Invest4.39M2.87%13.48K
Vanguard Total Stock Mkt Idx Inv4.38M2.86%-421.42K
Vanguard Morn Total Stk Mkt Idx Investor4.38M2.86%-421.42K
Vanguard US Total Market Shares ETF4.36M2.78%3.80K
iShares Russell 2000 ETF3.68M2.41%-65.38K
Vanguard Small Cap Index3.17M2.07%8.09K
SPDR® S&P Biotech ETF2.30M1.45%5.12K
State Street® SPDR® S&P® Biotech ETF2.10M1.37%4.82K
Vanguard MStar Small Cap Growth Indx Inv1.83M1.20%8.31K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 24, 2025Echelard Yann-Sell$162.85K
Sep 11, 2025Lonial Sagar-Sell$672.27K
Jun 13, 2025Echelard Yann-Sell$369.40K
Jan 03, 2025Power Sean A CFOSell$343.44K
Jan 06, 2025Power Sean A CFOSell$285.94K

Insider Transactions Trends

DateBuySell
2026 Q3--
2026 Q2--
2026 Q1--
2025 Q4-1
2025 Q3-1

TGTX Ownership FAQ

Who Owns TG Therapeutics?

TG Therapeutics shareholders are primarily institutional investors at 77.80%, followed by 7.47% insiders and 14.73% retail investors. The average institutional ownership in TG Therapeutics's industry, Biotech Stocks , is 379.01%, which TG Therapeutics falls below.

Who owns the most shares of TG Therapeutics?

TG Therapeutics’s largest shareholders are Blackrock funding, inc. /de (22.05M shares, 15.27%), Vanguard group (15.84M shares, 10.89%), and Blackrock (11.39M shares, 7.79%). Together, they hold 33.95% of TG Therapeutics’s total shares outstanding.

Does Blackrock own TG Therapeutics?

Yes, BlackRock owns 7.79% of TG Therapeutics, totaling 11.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 202.6M$. In the last quarter, BlackRock increased its holdings by 544.84K shares, a 5.02% change.

Who is TG Therapeutics’s biggest shareholder by percentage of total assets invested?

M28 capital management lp is TG Therapeutics’s biggest shareholder by percentage of total assets invested, with 10.29% of its assets in 88.35K TG Therapeutics shares, valued at 4.85M$.

Who is the top mutual fund holder of TG Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of TG Therapeutics shares, with 5.24% of its total shares outstanding invested in 8.03M TG Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools